Patent Search and Filing

AstraZeneca Says U.S. Court Denies Teva Motion in Patent Case (Bloomberg.com)
Sept. 24 (Bloomberg) — AstraZeneca Plc , the U.K.’s second- biggest drugmaker, said a U.S. court denied a motion for summary judgment in a patent case concerning its Pulmicort asthma treatment.

This entry was posted on Wednesday, September 24th, 2008 at 5:51 pm and is filed under Patents. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.